Dr. Ulrich Hermanto, MD, PhD

Dr. Hermanto practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Hermanto's NPI, 1992916241, was assigned on May 25, 2007. Dr. Hermanto graduated from Icahn School Of Medicine At Mount Sinai in 2002. Dr. Hermanto holds New York license 244312.

Dr. Hermanto's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Hermanto's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. Dr. Hermanto is also affiliated with St. John's Riverside Hospital. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Hermanto to 2 more group practices and clinics, 2 medical groups and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hermanto practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Hermanto's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Hermanto is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Hermanto's licenses on file in 2 states: New York and Nevada.

Dmand AI lists bone cancer radiation, breast cancer radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Hermanto treats.

CMS data shows 841 Medicare services from Dr. Hermanto across 7 procedure codes in 2024, for 73 Medicare patients. Medicare paid $166,863 for them. Every service was in an office.

CMS counts 73 Medicare patients who saw Dr. Hermanto in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have cancer, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hermanto's median patient age at 69, with 44% women.

In 2024, Dr. Hermanto wrote 64 Medicare Part D claims for 30 patients. 94% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $395 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hermanto for performance year 2024, reported as part of a group. CMS lists Dr. Hermanto as offering telehealth.

Dmand AI links 9 papers to Dr. Hermanto, published from 2008 to 2021. The most frequent topics are Breast Neoplasms, Intraoperative Care and Mastectomy, Segmental. Dr. Hermanto has published most often in Ann Surg Oncol. Dr. Hermanto's most frequent co-authors are Kevin P. Bethke, MD, Sheen Cherian, MD and Nimisha Deb, MD.

Dmand AI lists 1 award for Dr. Hermanto, most recently CMS Stage 1 EHR in 2014.

Dr. Hermanto graduated from Icahn School Of Medicine At Mount Sinai in 2002.

Dr. Hermanto is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.